J.B.Chemicals & Pharmaceuticals Ltd. Share Price & Stock Analysis

J.B.Chemicals & Pharmaceuticals Ltd. (BSE: 506943) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹0 Cr, it ranks #5,551 by market cap among the 6,197 Indian listed companies on FinBizNet, and #85 of 86 in Medicinal Chemicals and Botanical Products. At ₹2,416.10 (as of 16 Nov 2026), the share price is 4.3% below its 52-week high of ₹2,525.50 and 1.5% above its 52-week low of ₹2,380.00. The share price is up 43.0% over one year and up 17.9% over three months.

Key Metrics

Current Price₹2,416.10
Market Cap₹0 Cr
BSE Code506943
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
Return on Equity18.69%
Return on Assets12.48%
52-Week Range₹2,380.00 – ₹2,525.50
1-Year Price Change+43.0%
3-Month Price Change+17.9%
HeadquartersMumbai, Maharashtra
Websitewww.jbpharma.com

Latest Quarterly Results — Q4 FY26

Revenue₹904 Cr
Net Profit₹101 Cr
Net Margin11.2%
EPS (Basic)₹6.35
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

J.B.Chemicals & Pharmaceuticals Ltd. Quarterly Revenue and Profit Trend

J.B.Chemicals & Pharmaceuticals Ltd. reported revenue of ₹904 Cr in Q4 FY26, down 4.8% from ₹949 Cr in Q4 FY25 and down 15.1% from ₹1,065 Cr in Q3 FY26. It posted a net profit of ₹101 Cr for the quarter, against a net profit of ₹146 Cr in Q4 FY25 (down 30.4%). Across the 5 quarters from Q4 FY25 to Q4 FY26, quarterly revenue ranged from ₹904 Cr (Q4 FY26) to ₹1,094 Cr (Q1 FY26). The company was profitable in each of these 5 quarters.

QuarterRevenueNet ProfitNet Margin
Q4 FY26₹904 Cr₹101 Cr11.2%
Q3 FY26₹1,065 Cr₹198 Cr18.6%
Q2 FY26₹1,085 Cr₹208 Cr19.2%
Q1 FY26₹1,094 Cr₹202 Cr18.5%
Q4 FY25₹949 Cr₹146 Cr15.3%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 48.80% of J.B.Chemicals & Pharmaceuticals Ltd.'s shares as of Mar 2026, against 47.73% in Jun 2025 (+1.07 percentage points).

About J.B.Chemicals & Pharmaceuticals Ltd.

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, the company offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. It provides its products to gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-anal

Products and Services

1. Pharmaceuticals-This segment manufactures and markets a range of pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients.

Business Segments

1. Pharmaceuticals-100%

J.B.Chemicals & Pharmaceuticals Ltd. vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
J.B.Chemicals & Pharmaceuticals Ltd.₹0 Cr—18.69%₹904 Cr+43.0%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of J.B.Chemicals & Pharmaceuticals Ltd.?

J.B.Chemicals & Pharmaceuticals Ltd. is trading at ₹2,416.10, with a market capitalisation of ₹0 Cr.

Which sector does J.B.Chemicals & Pharmaceuticals Ltd. belong to?

J.B.Chemicals & Pharmaceuticals Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of J.B.Chemicals & Pharmaceuticals Ltd.?

J.B.Chemicals & Pharmaceuticals Ltd. has a return on equity of 18.69%.

What is the stock symbol of J.B.Chemicals & Pharmaceuticals Ltd.?

J.B.Chemicals & Pharmaceuticals Ltd. is listed on the BSE under the scrip code 506943.

How has J.B.Chemicals & Pharmaceuticals Ltd.'s share price moved over the past year?

J.B.Chemicals & Pharmaceuticals Ltd.'s share price is up 43.0% over one year and up 17.9% over three months. Its 52-week range is ₹2,380.00 to ₹2,525.50.

What were J.B.Chemicals & Pharmaceuticals Ltd.'s latest quarterly results?

In Q4 FY26, J.B.Chemicals & Pharmaceuticals Ltd. reported revenue of ₹904 Cr and net profit of ₹101 Cr, with basic EPS of ₹6.35 (consolidated, parsed from the company's exchange filing).

How have J.B.Chemicals & Pharmaceuticals Ltd.'s revenue and profit changed over the past year?

J.B.Chemicals & Pharmaceuticals Ltd. reported revenue of ₹904 Cr in Q4 FY26, down 4.8% from ₹949 Cr in Q4 FY25 and down 15.1% from ₹1,065 Cr in Q3 FY26.

What is the promoter holding in J.B.Chemicals & Pharmaceuticals Ltd.?

Promoters held 48.80% of J.B.Chemicals & Pharmaceuticals Ltd.'s shares as of Mar 2026, against 47.73% in Jun 2025 (+1.07 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.